Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors

US9266855B2 · kind B2 · utility

Assignee

• Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

• Sean Colm Turner · Ludwigshafen, DE
• Margaretha Henrica Maria Bakker · Ludwigshafen, DE
• Marcel van Gaalen · Ludwigshafen, DE
• Falko Ernst Wolter · Mannheim, DE
• Wilfried Hornberger · Wiesbaden, DE
• Marjoleen Nijsen · Libertyville, US

Key dates

• Filing date: Sep 26, 2011
• Grant date: Feb 23, 2016
• Expiry date: Nov 7, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D401/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel heterocyclic compounds which are useful for inhibiting glycogen synthase kinase 3 (GSK-3), methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.